Bad News Continues for This Defensive TSX Stock

What next for Norbord investors after a 60% decline in stock price?

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The effects of the coronavirus lockdown will start showing in the earnings for the first quarter of 2020. Most companies in the non-essential space have cut down production or suspended operations. During times like these, it is natural to look at market leaders. However, it looks like COVID-19 has not spared even industry giants. Sometimes, everyone has to take a punch.

Norbord is a leading player in the OSD segment

Norbord Inc (TSX:NBD)(NYSE:OSB) is a leading global manufacturer of wood-based panels and the world’s largest producer of oriented strand board (OSB). Norbord’s business is closely linked to the U.S. housing sector. The data coming out from there is not great.

The Commerce Department said that U.S. home-construction activity collapsed in March, with housing starts falling to 1.2 million units, down from 1.56 million units in February, a drop of 22.3%. This is the worst monthly decline for housing since March 1984. Single-family homes fell 17.5%, while apartments and condo fell 32.1% from February. It is likely that the situation will not improve in April either.

In response, Norbord has adjusted its operating configuration by reducing shifts and running a number of its North American mills on alternating schedules. This adjusted operating configuration will initially result in a 25% reduction to Norbord’s currently operating North American mill capacity.

“These are extraordinary times and difficult decisions, but they reflect the uncertainties facing businesses around the globe,” said Norbord President and CEO Peter Wijnbergen.

Norbord’s European business is prepared to take similar action and will adjust mill operating schedules as needed to match production with demand. The company does not intend to provide further operational updates unless there is a significant change in this curtailment strategy.

Norbord is lower capital expenditure

In addition, Norbord is deferring non-critical capital projects and further reducing its 2020 capital expenditures budget by 25%, from US$100 million to US$75 million, to preserve cash and balance sheet flexibility.

This continues a spate of bad numbers for Norbord. In 2019, the company reported an EBITDA of $138 million compared to $724 million in 2018 on significantly lower realized North American OSB prices and shipment volumes, as well as lower European panel prices.

“2019 was a challenging year for Norbord,” said Peter Wijnbergen. “Our financial results were disappointing relative to our record performance in 2018, as the slowdown in U.S. housing starts through most of 2019 decreased North American OSB demand and a slowing of German industrial production put downward pressure on European panel prices.” From the looks of it, 2020 doesn’t seem to be doing any better. It is in fact worse.

When the markets open up and home construction activity picks up, it’ll be Norbord that’ll benefit the most because of its ability to hold up during the crisis. It is this development that analysts are gunning for — and why they have given Norbord a price target of $23.37, an upside of over 35% from its current prices.

But a lot will have to go right for Norbord to achieve this target. Right now investors can look to benefit from the stock’s high dividend yield of 7.3%.

Norbord is declaring its first-quarter results for 2020 in the first week of May. That’ll give us a lot more clarity on the future of this stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »